ATE467834T1 - Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen - Google Patents

Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen

Info

Publication number
ATE467834T1
ATE467834T1 AT03727020T AT03727020T ATE467834T1 AT E467834 T1 ATE467834 T1 AT E467834T1 AT 03727020 T AT03727020 T AT 03727020T AT 03727020 T AT03727020 T AT 03727020T AT E467834 T1 ATE467834 T1 AT E467834T1
Authority
AT
Austria
Prior art keywords
mps
oligosaccharide
target
solution
mucopolysaccharidoses
Prior art date
Application number
AT03727020T
Other languages
English (en)
Inventor
Peter Meikle
Maria Fuller
Steve Ramsey
Enzo Ranieri
John Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE467834T1 publication Critical patent/ATE467834T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT03727020T 2002-06-14 2003-06-13 Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen ATE467834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS2930A AUPS293002A0 (en) 2002-06-14 2002-06-14 Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
PCT/AU2003/000731 WO2003106997A1 (en) 2002-06-14 2003-06-13 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders

Publications (1)

Publication Number Publication Date
ATE467834T1 true ATE467834T1 (de) 2010-05-15

Family

ID=3836492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727020T ATE467834T1 (de) 2002-06-14 2003-06-13 Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen

Country Status (11)

Country Link
US (1) US20060286034A1 (de)
EP (2) EP1532438B1 (de)
JP (1) JP2005530157A (de)
AT (1) ATE467834T1 (de)
AU (2) AUPS293002A0 (de)
CA (1) CA2488811A1 (de)
DE (1) DE60332538D1 (de)
NO (1) NO20050186L (de)
NZ (1) NZ537512A (de)
TW (1) TW200400351A (de)
WO (1) WO2003106997A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003231220A1 (en) 2002-04-30 2003-11-17 Saint Louis University A method for detecting lysosomal storage diseases
EP1616193B1 (de) 2003-03-31 2012-03-21 Women's And Children's Hospital Multiplex-screening auf lysosomale speicherkrankheiten (lsds)
JPWO2005050191A1 (ja) * 2003-10-27 2007-11-29 宏 葛西 酸化的損傷グアニン化合物とこれの濃度補正物質の同時分析方法及びこの分析方法に用いる分析装置
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
US20070161074A1 (en) * 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
SI2245145T1 (sl) 2008-01-18 2017-05-31 Biomarin Pharmaceutical Inc. Izdelava aktivnih visoko fosforiliranih humanih encimov lizosomske sulfataze in njihova uporaba
JP2009229426A (ja) * 2008-03-25 2009-10-08 Sumitomo Bakelite Co Ltd 糖鎖分析法
EP2304421A4 (de) 2008-07-23 2017-05-31 P Devices Inc. Tragbare diagnosevorrichtung auf plasmabasis und diagnoseverfahren dafür
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US8232073B2 (en) * 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8592140B2 (en) 2009-01-02 2013-11-26 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US9029530B2 (en) 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
CN104114686A (zh) * 2011-11-07 2014-10-22 夏尔人类遗传性治疗公司 Sanfilippo综合征的生物标志物及其用途
US9982288B2 (en) * 2014-04-30 2018-05-29 The Nemours Foundation Mucopolysaccharidosis IVA/VII screening and treatment method
MA40954A (fr) * 2014-11-14 2017-09-19 Shire Human Genetic Therapies Détermination de niveaux de glycosaminoglycane par spectrométrie de masse
CN107941963A (zh) * 2017-12-29 2018-04-20 珍奥集团股份有限公司 一种增加骨密度保健食品中盐酸氨基葡萄糖与硫酸软骨素的含量测定方法
CN116124971A (zh) * 2018-08-07 2023-05-16 江苏双林海洋生物药业有限公司 农产品中氨基葡萄糖含量的检测方法
CN108872441B (zh) * 2018-08-14 2021-09-03 江苏康缘药业股份有限公司 一种测定氨基葡萄糖和硫酸软骨素的方法
CN109781997A (zh) * 2019-01-22 2019-05-21 中国人民解放军总医院 用于诊断粘多糖病ⅱ型的生物标志物及其应用
CN114264741B (zh) * 2021-12-15 2022-08-19 山东大学 一种鉴别猪来源肝素是否掺反刍类动物肝素的方法
IT202200007808A1 (it) 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
CN115032377B (zh) * 2022-08-11 2022-11-01 裕菁科技(上海)有限公司 一种粘多糖贮积症生物标记物及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310646A (en) * 1988-05-13 1994-05-10 Regents Of The University Of Minnesota Method for the detection of mucopolysaccharide storage diseases
US5310464A (en) 1991-01-04 1994-05-10 Redepenning Jody G Electrocrystallization of strongly adherent brushite coatings on prosthetic alloys
US6506384B1 (en) * 1997-12-31 2003-01-14 New York University Early detection of mycobacterial disease
NZ507949A (en) * 1998-09-25 2002-03-01 Tokyo Gas Co Ltd C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
RU2196988C2 (ru) * 2000-04-19 2003-01-20 Государственный новосибирский областной клинический диагностический центр Способ диагностики мукополисахаридозов
JP2004501365A (ja) * 2000-06-07 2004-01-15 デューク・ユニヴァーシティ ポンペ病および他のグリコーゲン貯蔵病のため診断方法
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids

Also Published As

Publication number Publication date
DE60332538D1 (de) 2010-06-24
JP2005530157A (ja) 2005-10-06
EP1532438A1 (de) 2005-05-25
NO20050186L (no) 2005-03-10
AUPS293002A0 (en) 2002-07-04
EP2081023A3 (de) 2009-10-07
AU2003233255B2 (en) 2009-02-19
CA2488811A1 (en) 2003-12-24
EP1532438A4 (de) 2006-12-06
US20060286034A1 (en) 2006-12-21
TW200400351A (en) 2004-01-01
NO20050186D0 (no) 2005-01-13
EP1532438B1 (de) 2010-05-12
WO2003106997A1 (en) 2003-12-24
EP2081023A2 (de) 2009-07-22
AU2003233255C1 (en) 2009-07-16
NZ537512A (en) 2006-09-29
AU2003233255A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
NO20050186D0 (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
EP2851369A3 (de) Verfahren für die Diagnose von Demenz und anderen neurologischen Erkrankungen
US20090011452A1 (en) Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy
DE69905310D1 (de) Reflexalgorithmus zur frühen und kostengünstigen Diagnose von myokardischen Infarkten geeignet für automatisierte diagnostische Plattformen
WO2004058044A3 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
KR20150052311A (ko) Ｆｔ-ｉｃｒ-ｍｓ/ｍｓ를 이용한 치은염 및 치주염의 바이오마커에 대한 타액 프로테옴의 분석
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
JP2016527480A (ja) 神経変性疾患に関連する方法及び組成物
Strohmaier et al. Spot urine samples for the metabolic evaluation of urolithiasis patients
DE60232595D1 (de) Methode zur diagnose von nierenerkrankungen
JP2009537797A (ja) 神経変性疾患の診断及び早期診断のためのｉｎｖｉｔｒｏ方法
ATE314648T1 (de) Diagnostisches verfahren für asthma
JP2020064055A (ja) 脂肪性肝疾患の検出又はリスクの予測方法、脂肪性肝疾患を検出するための診断薬キット及びバイオマーカー、対象の肝線維化の進行度の判定方法、並びに対象の肝線維化の進行度を判定するためのバイオマーカー
JP2020034538A (ja) 脂肪性肝疾患の検出又はリスクの予測方法、脂肪性肝疾患を検出するための診断薬キット及びバイオマーカー、対象の肝線維化の進行度の判定方法、並びに対象の肝線維化の進行度を判定するためのバイオマーカー
Tharwat The cardiac biomarker troponin I and other haematological and biochemical variables in downer camels (Camelus dromedarius)
WO2009026153A1 (en) Biomarkers for alzheimer's disease and methods using the same
Kim et al. Reference intervals for plasma amyloid β in korean adults without cognitive impairment
DE102008022609B4 (de) Verfahren zum Nachweis des Vorkommens von Nierensteinen und/oder Entzündungen der ableitenden Harnwege
RU2157528C1 (ru) Способ прогнозирования злокачественных новообразований
Arndt Normal values and reference intervals
ATE237276T1 (de) Automatisches diagnosesystem zur durchführung von immunoassays und klinisch-chemischen assays nach einem reflexalgorithmus
WO2020044500A1 (ja) 脂肪性肝疾患の検出又はリスクの予測方法、脂肪性肝疾患を検出するための診断薬キット及びバイオマーカー、対象の肝線維化の進行度の判定方法、並びに対象の肝線維化の進行度を判定するためのバイオマーカー
JP2023096904A (ja) 歯周病罹患リスク判定用マーカー及びその用途
RU2252420C1 (ru) Способ прогнозирования течения остеомиелита у детей
JP2020153767A (ja) 被検動物における急性期のｂａｄの発症可能性の評価方法及び急性期の分岐粥腫型梗塞の診断薬

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties